loading
Schlusskurs vom Vortag:
$2.51
Offen:
$2.47
24-Stunden-Volumen:
94,583
Relative Volume:
0.70
Marktkapitalisierung:
$72.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.52M
KGV:
-0.8646
EPS:
-2.88
Netto-Cashflow:
$-56.92M
1W Leistung:
-1.58%
1M Leistung:
+2.89%
6M Leistung:
+21.46%
1J Leistung:
-91.44%
1-Tages-Spanne:
Value
$2.45
$2.575
1-Wochen-Bereich:
Value
$2.45
$2.575
52-Wochen-Spanne:
Value
$1.25
$28.70

Aerovate Therapeutics Inc Stock (AVTE) Company Profile

Name
Firmenname
Aerovate Therapeutics Inc
Name
Telefon
617-443-2400
Name
Adresse
930 WINTER STREET, WALTHAM
Name
Mitarbeiter
4
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
AVTE's Discussions on Twitter

Vergleichen Sie AVTE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AVTE
Aerovate Therapeutics Inc
2.49 72.17M 0 -75.52M -56.92M -2.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-18 Herabstufung Evercore ISI Outperform → In-line
2024-06-18 Herabstufung TD Cowen Buy → Hold
2024-06-18 Herabstufung Wells Fargo Overweight → Equal Weight
2024-06-17 Herabstufung BTIG Research Buy → Neutral
2024-06-17 Herabstufung Guggenheim Buy → Neutral
2024-06-17 Herabstufung Wedbush Outperform → Neutral
2024-03-25 Fortgesetzt Jefferies Buy
2023-12-08 Eingeleitet Wells Fargo Equal Weight
2023-03-01 Eingeleitet Guggenheim Buy
2022-12-06 Hochstufung BTIG Research Neutral → Buy
2022-09-19 Fortgesetzt Wedbush Outperform
2022-08-16 Herabstufung BTIG Research Buy → Neutral
2022-02-11 Eingeleitet BTIG Research Buy
2021-07-26 Eingeleitet Cowen Outperform
2021-07-26 Eingeleitet Evercore ISI Outperform
2021-07-26 Eingeleitet Jefferies Buy
2021-07-26 Eingeleitet Wedbush Outperform
Alle ansehen

Aerovate Therapeutics Inc Aktie (AVTE) Neueste Nachrichten

pulisher
Apr 03, 2025

36,897 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Acquired by Corient Private Wealth LLC - Defense World

Apr 03, 2025
pulisher
Mar 31, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AMPY, HEES, AVTE, TGI to Act Now - GlobeNewswire Inc.

Mar 31, 2025
pulisher
Mar 27, 2025

Aerovate Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

Aerovate Therapeutics Inc. (AVTE) reports earnings - Quartz

Mar 27, 2025
pulisher
Mar 21, 2025

Aerovate Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Business Wire

Mar 21, 2025
pulisher
Mar 20, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, PTMN, AVTE on Behalf of Shareholders - The Malaysian Reserve

Mar 20, 2025
pulisher
Mar 17, 2025

Aerovate Therapeutics (AVTE) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 17, 2025
pulisher
Feb 28, 2025

FY2029 Earnings Estimate for AVTE Issued By Wedbush - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

FY2029 Earnings Forecast for AVTE Issued By Wedbush - Defense World

Feb 27, 2025
pulisher
Feb 25, 2025

In Another Blow to Delaware's Hegemony Another Company Proposes Reincorporation in Nevada - The National Law Review

Feb 25, 2025
pulisher
Feb 24, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCCNE, LGTY, AVTE, PLYA - Longview News-Journal

Feb 24, 2025
pulisher
Feb 24, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders - Stockhouse Publishing

Feb 24, 2025
pulisher
Feb 20, 2025

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Increase in Short Interest - MarketBeat

Feb 20, 2025
pulisher
Feb 17, 2025

Ready to Jump After Recent Trade: Aerovate Therapeutics Inc (AVTE) - SETE News

Feb 17, 2025
pulisher
Feb 17, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders - EIN News

Feb 17, 2025
pulisher
Feb 09, 2025

Deltec Asset Management LLC Invests $514,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

Feb 09, 2025
pulisher
Feb 04, 2025

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Growth in Short Interest - MarketBeat

Feb 04, 2025
pulisher
Jan 26, 2025

Barclays PLC Raises Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jan 26, 2025
pulisher
Jan 26, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MHLD, IPG, AVTE on Behalf of Shareholders - GlobeNewswire

Jan 26, 2025
pulisher
Jan 17, 2025

Aerovate Therapeutics Target of Unusually Large Options Trading (NASDAQ:AVTE) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Jane Street Group LLC Trims Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Jane Street Group LLC Trims Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Increases By 35.5% - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Unusually active option classes on open January 16th - TipRanks

Jan 16, 2025
pulisher
Jan 12, 2025

Geode Capital Management LLC Sells 25,287 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

Barclays PLC Has $39,000 Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jan 11, 2025
pulisher
Jan 11, 2025

Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World

Jan 11, 2025
pulisher
Jan 03, 2025

State Street Corp Raises Stock Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Jan 03, 2025
pulisher
Dec 28, 2024

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire

Dec 28, 2024
pulisher
Dec 27, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders - The Eastern Progress Online

Dec 27, 2024
pulisher
Dec 22, 2024

Fmr LLC Boosts Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Dec 22, 2024
pulisher
Dec 21, 2024

Charles Schwab Investment Management Inc. Reduces Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerAVTE, BCOV, ALVR, AE - cnhinews.com

Dec 20, 2024
pulisher
Dec 19, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 5.3% in November - MarketBeat

Dec 17, 2024
pulisher
Dec 16, 2024

INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - The Eastern Progress Online

Dec 16, 2024
pulisher
Dec 16, 2024

Verition Fund Management LLC Sells 149,137 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World

Dec 16, 2024
pulisher
Dec 13, 2024

Pulmonary Arterial Hypertension Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen Pharma, Aerovate - The Globe and Mail

Dec 13, 2024

Finanzdaten der Aerovate Therapeutics Inc-Aktie (AVTE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):